期刊： PROSTATE CANCER AND PROSTATIC DISEASES, 2023; ()
Background Abiraterone (Abi) is an androgen receptor signaling inhibitor that significantly improves patients' life expectancy in metastatic prostate ......
期刊： PROSTATE CANCER AND PROSTATIC DISEASES, 2023; 26 (2)
Background Many factors are implicated in the potential 'under-treatment' of prostate cancer but little is known about the between-hospital variation.......
期刊： PROSTATE CANCER AND PROSTATIC DISEASES, 2023; 26 (2)
Background and objectives The Reporting and Data System (RADS) have been used in the attempts to standardize the results of oncological scans in diffe......
期刊： PROSTATE CANCER AND PROSTATIC DISEASES, 2023; ()
IntroductionTo determine associations between prostate cancer (PCa) tumor burden measured on biopsy or multiparametric magnetic resonance imaging (mpM......
期刊： PROSTATE CANCER AND PROSTATIC DISEASES, 2023; 26 (3)
BACKGROUND: Human ejaculation can be defined as a complex and still largely unknown function. Since decades, Benign Prostatic Hyperplasia ( BPH) surge......
期刊： PROSTATE CANCER AND PROSTATIC DISEASES, 2023; ()
BackgroundThe top-down holmium laser enucleation of the prostate (HoLEP) technique recently emerged as a safe and effective modification of traditiona......
期刊： PROSTATE CANCER AND PROSTATIC DISEASES, 2023; 26 (3)
Background Retzius-sparing robot-assisted radical prostatectomy (RARP) is not yet universally accepted due to still limited functional data and some c......
期刊： PROSTATE CANCER AND PROSTATIC DISEASES, 2023; 26 (3)
Background: Currently, transperineal prostate biopsy (TPB) is preferred over transrectal biopsy (TRB) because of less infectious complications and imp......
期刊： PROSTATE CANCER AND PROSTATIC DISEASES, 2023; ()
ObjectivesThe prognostic capacity of positive surgical margins (PSM) for biochemical recurrence (BCR) is unclear, with inconsistent findings across pu......
期刊： PROSTATE CANCER AND PROSTATIC DISEASES, 2023; ()
BackgroundRobot-Assisted Simple Prostatectomy (RASP) has emerged as a promising alternative in the treatment of benign prostatic obstruction (BPO). Ho......
期刊： PROSTATE CANCER AND PROSTATIC DISEASES, 2023; 26 (2)
Purpose To evaluate the diagnostic performance of follow-up multiparametric MRI for prediction of recurrent prostate cancer after high-intensity focus......
期刊： PROSTATE CANCER AND PROSTATIC DISEASES, 2023; 26 (3)
Background: The IP1-PROSTAGRAM study showed that a short, non-contrast MRI detected more significant cancers with similar rates of biopsy compared to ......
